Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TPST Tempest Therapeutics Inc.

未开盘 11-12 16:00:00 EST

0.3830

-0.0140

-3.53%

盘后0.3899

+0.0069+1.80%

19:44 EST

最高0.3997	最低0.3701	成交量13.18万
今开0.3790	昨收0.3970	日振幅7.46%
总市值765.82万	流通市值571.46万	总股本2,000万
成交额5.09万	换手率0.88%	流通股本1,492万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TPST","market":"US","secType":"STK","nameCN":"Tempest Therapeutics Inc.","latestPrice":0.383,"timestamp":1794517200000,"preClose":0.397,"halted":0,"volume":131765,"hourTrading":{"tag":"盘后","latestPrice":0.3899,"preClose":0.383,"latestTime":"19:44 EST","volume":20366,"amount":7650.8679,"timestamp":1794530657293,"change":0.0069,"changeRate":0.018016,"amplitude":0.065535},"delay":0,"changeRate":-0.03526448362720406,"floatShares":14920600,"shares":19995400,"eps":-4.561698,"marketStatus":"未开盘","change":-0.014,"latestTime":"11-12 16:00:00 EST","open":0.379,"high":0.3997,"low":0.3701,"amount":50920.90970955,"amplitude":0.074559,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.561698,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794560400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.397,"preHourTrading":{"tag":"盘前","latestPrice":0.4,"preClose":0.397,"latestTime":"09:18 EST","volume":12516,"amount":4929.51759132,"timestamp":1794493115485,"change":0.003,"changeRate":0.007557,"amplitude":0.150378},"postHourTrading":{"tag":"盘后","latestPrice":0.3899,"preClose":0.383,"latestTime":"19:44 EST","volume":20366,"amount":7650.8679,"timestamp":1794530657293,"change":0.0069,"changeRate":0.018016,"amplitude":0.065535},"volumeRatio":0.272514,"impliedVol":1.4125,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TPST","defaultTab":"news","newsList":[{"id":"1196531235","title":"Tempest Therapeutics与河北森朗生物达成独家选择权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1196531235","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196531235?lang=zh_cn&edition=full","pubTime":"2026-09-16 04:11","pubTimestamp":1789503083,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc.（以下简称“Tempest”）近日宣布，已与河北森朗生物科技有限公司正式签署一项独家选择权协议。这一战略合作标志着双方在生物技术领域迈出了关键一步。\n根据协议条款，Tempest获得了特定权利的独家选择权，这为其未来的研发管线布局提供了更大的灵活性和战略纵深。此举或将为双方在相关治疗领域的深度合作铺平道路。\n尽管协议的具体财务细节暂未披露，但业界普遍认为，此类独家选择权安排往往预示着后续潜在的重大合作可能性。Tempest通过这一举措，进一步强化了其在生物医药创新生态中的链接能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117687625","title":"Tempest Therapeutics公布最新安全数据：截至2026年8月25日未见3级及以上细胞因子释放综合征或神经毒性病例","url":"https://stock-news.laohu8.com/highlight/detail?id=1117687625","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117687625?lang=zh_cn&edition=full","pubTime":"2026-09-16 04:07","pubTimestamp":1789502837,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics今日披露了其临床试验中的最新安全监测结果。数据显示，截至2026年8月25日，在接受治疗的患者群体中，尚未观察到任何3级或更高级别的细胞因子释放综合征病例，同时亦未发现相关神经毒性事件。此项安全性评估结果无疑为该公司在研疗法的临床推进注入了积极信号。细胞因子释放综合征及神经毒性，作为免疫相关治疗中备受关注的潜在不良反应，其发生率的可控性对疗法能否顺利获得监管审批及后续商业化落地而言，至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147881183","title":"Tempest获得临床阶段CD7靶向慢病毒体内CAR-T平台的独家授权选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=1147881183","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147881183?lang=zh_cn&edition=full","pubTime":"2026-09-16 04:06","pubTimestamp":1789502770,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc.近日宣布，已成功获得一项独家选择权，旨在许可一个处于临床阶段的、靶向CD7的慢病毒体内CAR-T平台。根据协议条款，Tempest有权在特定条件下行使该选择权，以获取平台的全球独家开发和商业化权益。Tempest若能成功整合该平台，或将提升其在竞争激烈的肿瘤治疗市场中的地位。此次协议的达成，反映了Tempest致力于通过创新技术平台来应对未满足医疗需求的坚定承诺。随着更多细节的披露，业界将密切关注这一潜在合作对Tempest长期价值的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106640486","title":"Tempest Therapeutics任命Nicholas Rossettos为首席财务官及首席财务与会计官 自2026年9月1日起生效——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1106640486","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106640486?lang=zh_cn&edition=full","pubTime":"2026-08-25 04:45","pubTimestamp":1787604310,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc.（纳斯达克代码：TPST）今日宣布，根据提交至美国证券交易委员会（SEC）的文件显示，公司已正式任命Nicholas Rossettos为首席财务官（CFO）兼首席财务与会计官，该任命自2026年9月1日起正式生效。\n这一关键人事变动标志着公司在财务管理层面迈出重要一步，旨在强化其财务领导团队并推动战略发展。SEC文件披露了上述人事调整的具体安排，确认了Rossettos的履新职责范围。此次高管变更反映了公司对治理结构和财务运营效率的持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158572554","title":"Tempest Therapeutics公司高管变动：Justin Trojanowski将于9月1日卸任首席财务官及首席会计官职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1158572554","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158572554?lang=zh_cn&edition=full","pubTime":"2026-08-25 04:45","pubTimestamp":1787604309,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics Inc.近日向美国证券交易委员会提交的文件披露，公司首席财务官兼首席会计官Justin Trojanowski即将离任。根据这份监管文件，Trojanowski的离职将于今年9月1日正式生效。这一人事变动标志着该公司财务领导层将迎来新的调整期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144069314","title":"Tempest宣布与森朗生物就靶向CD7的下一代体内CAR-T疗法TPST-4003达成开发合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1144069314","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144069314?lang=zh_cn&edition=full","pubTime":"2026-07-21 19:01","pubTimestamp":1784631681,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics公司宣布，已与森朗生物就TPST-4003的开发达成合作。TPST-4003是一款靶向CD7的下一代体内嵌合抗原受体T细胞（CAR-T）疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149312324","title":"Tempest Therapeutics股东拟出售至多243万股普通股 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1149312324","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149312324?lang=zh_cn&edition=full","pubTime":"2026-06-27 04:04","pubTimestamp":1782504256,"startTime":"0","endTime":"0","summary":"据美国证券交易委员会（SEC）最新文件披露，Tempest Therapeutics Inc. 的部分现有股东计划出售其持有的公司普通股，出售股份数量最高可达243万股。此次股份出售计划由售股股东自主发起，公司本身并未发行新股或从此次出售中获得任何收益。文件显示，相关股份将根据市场情况，通过或不时在公开市场以市价交易、与市价相关的定价交易、协商交易或其他法律允许的方式进行处置。此举通常反映了股东基于自身财务规划或投资策略的考量，公司运营与资金状况不受直接影响。投资者需关注后续实际出售的规模、时机及对二级市场流动性的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117418065","title":"Tempest风险解决方案任命David Näslund为新任首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1117418065","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117418065?lang=zh_cn&edition=full","pubTime":"2026-05-20 20:30","pubTimestamp":1779280258,"startTime":"0","endTime":"0","summary":"Tempest Security AB宣布，David Näslund已被任命为Tempest风险解决方案的新任首席执行官。\nDavid Näslund将自其当前担任Verifiera首席执行官的职位加入该公司，并将于2026年6月1日正式履新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517923710","title":"Tempest Therapeutics, Inc.盘中异动 下午盘股价大涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517923710?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:27","pubTimestamp":1741202872,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时27分，Tempest Therapeutics, Inc.股票出现异动，股价大幅上涨5.22%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.05%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032752abea042e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032752abea042e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514033299","title":"Tempest Therapeutics, Inc.盘中异动 快速下挫5.65%报0.781美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514033299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514033299?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:22","pubTimestamp":1740687755,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时22分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.65%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1923.81%、370.28%、193.42%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280422369895504d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280422369895504d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513217948","title":"Tempest Therapeutics, Inc.盘中异动 急速下跌5.06%报0.861美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513217948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513217948?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:59","pubTimestamp":1740171553,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时59分，Tempest Therapeutics, Inc.股票出现波动，股价急速下跌5.06%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222045913abd7fddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222045913abd7fddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511578140","title":"Tempest Therapeutics, Inc.盘中异动 大幅上涨5.10%报0.944美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511578140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511578140?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:20","pubTimestamp":1739467238,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日01时20分，Tempest Therapeutics, Inc.股票出现异动，股价快速上涨5.10%。截至发稿，该股报0.944美元/股，成交量74.1309万股，换手率1.70%，振幅4.76%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214012039a244ce2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214012039a244ce2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510865671","title":"Tempest Therapeutics, Inc.盘中异动 早盘大幅拉升6.12%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510865671?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197882,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Tempest Therapeutics, Inc.股票出现波动，股价快速上涨6.12%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223122a240a1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223122a240a1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508141356","title":"Tempest Therapeutics, Inc.盘中异动 早盘快速下挫5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508141356?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593151,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.85%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322323298796f1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322323298796f1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506574582","title":"Tempest Therapeutics, Inc.盘中异动 临近收盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506574582","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506574582?lang=zh_cn&edition=full","pubTime":"2025-01-28 04:36","pubTimestamp":1738010218,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日04时36分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.03%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804365896126de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012804365896126de9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503964206","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503964206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503964206?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:33","pubTimestamp":1736951590,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时33分，Tempest Therapeutics, Inc.股票出现异动，股价急速下挫5.32%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Allovir, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.52%、56.84%、35.49%，振幅较大的相关个股有Onconetix, Inc.、Eterna Therapeutics Inc.、Klotho Neurosciences, Inc.，振幅分别为14.29%、12.79%、12.00%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522331098673ba1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522331098673ba1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503884275","title":"Tempest Therapeutics, Inc.盘中异动 早盘大幅下挫5.02%报0.902美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503884275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503884275?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778730,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Tempest Therapeutics, Inc.股票出现异动，股价快速下挫5.02%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2741.64%、1797.61%、390.72%，振幅较大的相关个股有Exicure, Inc.、Verrica制药、Champions Oncology, Inc.，振幅分别为110.04%、106.80%、101.18%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223210a2203f05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223210a2203f05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TPST","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494945384","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大跌5.26%报0.837美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494945384","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2494945384?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:22","pubTimestamp":1735312923,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时22分，Tempest Therapeutics, Inc.股票出现波动，股价快速跳水5.26%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232203a20c0948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232203a20c0948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TPST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493576415","title":"Tempest Therapeutics, Inc.盘中异动 早盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493576415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493576415?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:40","pubTimestamp":1734964825,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时40分，Tempest Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322402895eadbcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122322402895eadbcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TPST","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492167576","title":"Tempest Therapeutics, Inc.盘中异动 大幅拉升5.00%报0.840美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492167576","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492167576?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:41","pubTimestamp":1734363669,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时41分，Tempest Therapeutics, Inc.股票出现波动，股价大幅拉升5.00%。Tempest Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Tempest Therapeutics, Inc.公司简介：Tempest Therapeutics Inc 是一家开发小分子疗法的后期生物技术公司，通过直接杀死肿瘤细胞和激活肿瘤特异性免疫的机制治疗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216234109ab7cb525&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216234109ab7cb525&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TPST","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tempesttx.com","stockEarnings":[{"period":"1week","weight":0.0208},{"period":"1month","weight":-0.4378},{"period":"3month","weight":-0.6227},{"period":"6month","weight":-0.7907},{"period":"1year","weight":-0.956},{"period":"ytd","weight":-0.8666}],"compareEarnings":[{"period":"1week","weight":0.0329},{"period":"1month","weight":-0.0269},{"period":"3month","weight":-0.0248},{"period":"6month","weight":0.0243},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.1103}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tempest Therapeutics Inc成立于2011年4月5日。该公司是一家临床阶段的生物技术公司，致力于推进针对癌症和免疫学适应症的多元化细胞疗法和小分子候选药物组合。其研发管线包括用于多发性骨髓瘤的CD19/BCMA双靶点CAR-T疗法，以及用于肝细胞癌和家族性腺瘤性息肉病的小分子候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":0.012727},{"month":2,"riseRate":0.307692,"avgChangeRate":-0.032927},{"month":3,"riseRate":0.461538,"avgChangeRate":0.000618},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.113004},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011916},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.124765},{"month":7,"riseRate":0.214286,"avgChangeRate":-0.03977},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.030843},{"month":9,"riseRate":0.5,"avgChangeRate":-0.071754},{"month":10,"riseRate":0.428571,"avgChangeRate":0.849395},{"month":11,"riseRate":0.357143,"avgChangeRate":-0.091825},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.062561}],"exchange":"NASDAQ","name":"Tempest Therapeutics Inc.","nameEN":"Tempest Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tempest Therapeutics Inc.(TPST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tempest Therapeutics Inc.,TPST,Tempest Therapeutics Inc.股票,Tempest Therapeutics Inc.股票老虎,Tempest Therapeutics Inc.股票老虎国际,Tempest Therapeutics Inc.行情,Tempest Therapeutics Inc.股票行情,Tempest Therapeutics Inc.股价,Tempest Therapeutics Inc.股市,Tempest Therapeutics Inc.股票价格,Tempest Therapeutics Inc.股票交易,Tempest Therapeutics Inc.股票购买,Tempest Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tempest Therapeutics Inc.(TPST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tempest Therapeutics Inc.(TPST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}